BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10217182)

  • 1. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases.
    Alessandrino P; Bernasconi P; Caldera D; Colombo A; Bonfichi M; Malcovati L; Klersy C; Martinelli G; Maiocchi M; Pagnucco G; Varettoni M; Perotti C; Bernasconi C
    Bone Marrow Transplant; 1999 Mar; 23(6):533-7. PubMed ID: 10217182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC).
    Bredeson C; Malcolm J; Davis M; Bence-Bruckler I; Kearns B; Huebsch L
    Bone Marrow Transplant; 1997 Nov; 20(10):889-96. PubMed ID: 9404932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age.
    Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R
    Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
    Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
    Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac arrhythmia after infusion of cryopreserved stem cells.
    Keung YK; Lau S; Elkayam U; Chen SC; Douer D
    Bone Marrow Transplant; 1994 Sep; 14(3):363-7. PubMed ID: 7994256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.
    Hoyt R; Szer J; Grigg A
    Bone Marrow Transplant; 2000 Jun; 25(12):1285-7. PubMed ID: 10871734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL).
    Martín-Henao GA; Picón M; Limón A; Carmona M; Amill B; Azqueta C; López R; González-Barca E; Grañena A; Brunet S; García J
    Bone Marrow Transplant; 1999 Mar; 23(6):579-87. PubMed ID: 10217189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.
    Bredeson C; Leger C; Couban S; Simpson D; Huebsch L; Walker I; Shore T; Howson-Jan K; Panzarella T; Messner H; Barnett M; Lipton J
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):405-14. PubMed ID: 15148494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hematopoietic progenitor cells' temperature on cardiac arrhythmias in patients given peripheral blood progenitor cells.
    Donmez A; Zoghi M; Cagirgan S; Acarlar C; Tombuloglu M
    Transfus Apher Sci; 2006 Jun; 34(3):245-51. PubMed ID: 16931400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
    Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
    Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.